These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22755)

  • 1. Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine.
    Florvall L; Ask AL; Ogren SO; Ross SB
    J Med Chem; 1978 Jan; 21(1):56-63. PubMed ID: 22755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action.
    Florvall L; Fagervall I; Ask AL; Ross SB
    J Med Chem; 1986 Nov; 29(11):2250-6. PubMed ID: 3783587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of 4-methoxyphenethylamine derivatives as inhibitors of monoamine oxidase.
    Keller WJ; Ferguson GG
    J Pharm Sci; 1976 Oct; 65(10):1539-40. PubMed ID: 978418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 5. N-cyclopropyltryptamines, potent monoamine oxidase inhibitors.
    Winn M; Horrom BW; Rasmussen RR; Chappell EB; Plotnikoff NP
    J Med Chem; 1975 Apr; 18(4):437-8. PubMed ID: 1079054
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB
    Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition.
    Porsolt RD; Roux S; Drieu K
    Arzneimittelforschung; 2000 Mar; 50(3):232-5. PubMed ID: 10758773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-aminoethyl)-2,3-dihydroindoles.
    Florvall L; Kumar Y; Ask AL; Fagervall I; Rényi L; Ross SB
    J Med Chem; 1986 Aug; 29(8):1406-12. PubMed ID: 3735309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of MAO by substituted tryptamine analogues.
    Balsa D; Fernandez-Alvarez E; Tipton KF; Unzeta M
    J Neural Transm Suppl; 1990; 32():103-5. PubMed ID: 2089079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of toloxatone, antidepressive agents and various other reserpine antagonists on three behavior tests, in the mouse treated with nialamide].
    Gouret C; Raynaud G
    Therapie; 1975; 30(2):225-30. PubMed ID: 1080583
    [No Abstract]   [Full Text] [Related]  

  • 13. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives.
    Cruces MA; Elorriaga C; Fernández-Alvarez E
    Biochem Pharmacol; 1990 Aug; 40(3):535-43. PubMed ID: 2383286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A.
    Hurst JH; Kulakowski EC
    Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives.
    Reyes-Parada M; Scorza MC; Silveira R; Dajas F; Costa G; Tipton KF; Cassels BK
    Biochem Pharmacol; 1994 Apr; 47(8):1365-71. PubMed ID: 7514408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.
    McDonald IA; Lacoste JM; Bey P; Palfreyman MG; Zreika M
    J Med Chem; 1985 Feb; 28(2):186-93. PubMed ID: 3968682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3,4-dimethoxyphenethylamine derivatives on monoamine oxidase.
    Keller WJ; Ferguson GG
    J Pharm Sci; 1977 Jul; 66(7):1048-50. PubMed ID: 886445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of an indole-hydrazide derivative as inhibitor of mouse brain type A monoamine oxidase.
    Gurpegui M; Monge A; Fuentes JA
    Arzneimittelforschung; 1981; 31(10):1710-2. PubMed ID: 7198447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.